Variant report

Variant	nsv427795
Chromosome Location	chr7:100525848-100554827
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:495)
CpG islands
(count:366)
Chromatin interactive
region (count:20)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:495 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr7:100550350-100551274	K562	blood:	n/a	n/a
2	ATF2	chr7:100548745-100549225	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr7:100548761-100549286	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF3	chr7:100539857-100540347	A549	lung:	n/a	n/a
5	BACH1	chr7:100546926-100547169	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr7:100548883-100549254	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr7:100531451-100531625	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr7:100550402-100551274	K562	blood:	n/a	n/a
9	BCL11A	chr7:100541410-100541610	H1-hESC	embryonic stem cell:	n/a	n/a
10	BCL11A	chr7:100541399-100541689	H1-hESC	embryonic stem cell:	n/a	n/a
11	BCL3	chr7:100539936-100540507	A549	lung:	n/a	n/a
12	BCL3	chr7:100550248-100551440	A549	lung:	n/a	n/a
13	BCL3	chr7:100539798-100540395	A549	lung:	n/a	n/a
14	BHLHE40	chr7:100550595-100551382	K562	blood:	n/a	n/a
15	BHLHE40	chr7:100550634-100551200	GM12878	blood:	n/a	n/a
16	BRCA1	chr7:100553476-100553477	HepG2	liver:	n/a	n/a
17	BRCA1	chr7:100550256-100551378	HepG2	liver:	n/a	n/a
18	BRCA1	chr7:100550597-100551380	Hela-S3	cervix:	n/a	n/a
19	BRCA1	chr7:100550522-100551358	GM12878	blood:	n/a	n/a
20	BRCA1	chr7:100541869-100541920	Hela-S3	cervix:	n/a	n/a
21	BRCA1	chr7:100539866-100540334	Hela-S3	cervix:	n/a	n/a
22	CBX3	chr7:100541701-100542144	K562	blood:	n/a	n/a
23	CBX3	chr7:100529480-100530068	K562	blood:	n/a	n/a
24	CBX3	chr7:100550582-100551391	K562	blood:	n/a	n/a
25	CBX3	chr7:100541727-100542018	K562	blood:	n/a	n/a
26	CEBPB	chr7:100539905-100540293	A549	lung:	n/a	n/a
27	CEBPB	chr7:100539872-100540169	HepG2	liver:	n/a	n/a
28	CEBPB	chr7:100539869-100540427	A549	lung:	n/a	n/a
29	CEBPB	chr7:100539901-100540283	K562	blood:	n/a	n/a
30	CEBPB	chr7:100533123-100533328	HepG2	liver:	n/a	chr7:100533177-100533188
31	CEBPB	chr7:100539967-100540172	HepG2	liver:	n/a	n/a
32	CEBPB	chr7:100539852-100540476	Hela-S3	cervix:	n/a	n/a
33	CEBPB	chr7:100539911-100540254	H1-hESC	embryonic stem cell:	n/a	n/a
34	CEBPB	chr7:100539855-100540373	ECC-1	luminal epithelium:	n/a	n/a
35	CEBPB	chr7:100539892-100540275	K562	blood:	n/a	n/a
36	CEBPB	chr7:100533034-100533367	A549	lung:	n/a	chr7:100533177-100533188
37	CEBPB	chr7:100539673-100540581	MCF-7	breast:	n/a	n/a
38	CEBPB	chr7:100549541-100549829	A549	lung:	n/a	chr7:100549687-100549698
39	CEBPB	chr7:100539737-100540578	A549	lung:	n/a	n/a
40	CEBPB	chr7:100539939-100540214	K562	blood:	n/a	n/a
41	CEBPB	chr7:100548882-100549443	H1-hESC	embryonic stem cell:	n/a	n/a
42	CEBPB	chr7:100549521-100549841	K562	blood:	n/a	chr7:100549687-100549698
43	CEBPB	chr7:100539886-100540298	ECC-1	luminal epithelium:	n/a	n/a
44	CEBPB	chr7:100533172-100533239	Hela-S3	cervix:	n/a	chr7:100533177-100533188
45	CEBPB	chr7:100549547-100549857	HepG2	liver:	n/a	chr7:100549687-100549698
46	CEBPB	chr7:100539906-100540289	HepG2	liver:	n/a	n/a
47	CEBPB	chr7:100539733-100540496	MCF-7	breast:	n/a	n/a
48	CEBPB	chr7:100539927-100540254	IMR90	lung:	n/a	n/a
49	CEBPD	chr7:100539988-100540237	HepG2	liver:	n/a	n/a
50	CEBPZ	chr7:100550215-100551674	HepG2	liver:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:100541893-100541943	HRE	kidney:	n/a
2	chr7:100541893-100541943	Hela-S3	cervix:	n/a
3	chr7:100544704-100544754	AG04450	lung:	fetal
4	chr7:100544220-100544270	GM12878	blood:	n/a
5	chr7:100546752-100546802	SK-N-SH	brain:	n/a
6	chr7:100544220-100544270	K562	blood:	n/a
7	chr7:100546752-100546802	HNPCEpiC	eye:	n/a
8	chr7:100550138-100550188	HepG2	liver:	n/a
9	chr7:100541893-100541943	GM12878	blood:	n/a
10	chr7:100544220-100544270	AG04449	skin:	fetal
11	chr7:100541893-100541943	MCF-7	breast:	n/a
12	chr7:100541893-100541943	K562	blood:	n/a
13	chr7:100546752-100546802	PrEC	prostate:	n/a
14	chr7:100550138-100550188	U87	brain:	n/a
15	chr7:100544704-100544754	U87	brain:	n/a
16	chr7:100550138-100550188	HEK293	kidney:	embryo
17	chr7:100547176-100547226	HUVEC	blood vessel:	n/a
18	chr7:100550138-100550188	HCF	heart:	n/a
19	chr7:100547176-100547226	MCF10A-Er-Src	breast:	n/a
20	chr7:100544704-100544754	BJ	skin:	n/a
21	chr7:100541893-100541943	PrEC	prostate:	n/a
22	chr7:100546752-100546802	ovcar-3	ovarian:	n/a
23	chr7:100541893-100541943	CMK	blood:	n/a
24	chr7:100546752-100546802	HCT-116	colon:	n/a
25	chr7:100546752-100546802	AG09319	gingival:	n/a
26	chr7:100544704-100544754	AG09309	skin:	n/a
27	chr7:100544220-100544270	SK-N-SH_RA	brain:	n/a
28	chr7:100541893-100541943	SKMC	muscle:	n/a
29	chr7:100547176-100547226	GM19239	blood:	n/a
30	chr7:100550138-100550188	SAEC	small airway:	n/a
31	chr7:100546752-100546802	H1-hESC	embryonic stem cell:	embryo
32	chr7:100544704-100544754	LNCaP	prostate:	n/a
33	chr7:100547176-100547226	HRCEpiC	kidney:	n/a
34	chr7:100547176-100547226	HL-60	blood:	n/a
35	chr7:100547176-100547226	T-47D	breast:	n/a
36	chr7:100541893-100541943	GM12891	blood:	n/a
37	chr7:100544704-100544754	ProgFib	skin:	n/a
38	chr7:100550138-100550188	HIPEpiC	eye:	n/a
39	chr7:100550138-100550188	ProgFib	skin:	n/a
40	chr7:100541893-100541943	HUVEC	blood vessel:	n/a
41	chr7:100544704-100544754	HRPEpiC	eye:	n/a
42	chr7:100546752-100546802	IMR90	lung:	fetal
43	chr7:100544220-100544270	NHDF-neo	bronchial:	n/a
44	chr7:100547176-100547226	AG04449	skin:	fetal
45	chr7:100544704-100544754	HepG2	liver:	n/a
46	chr7:100544704-100544754	SK-N-SH	brain:	n/a
47	chr7:100544220-100544270	HCT-116	colon:	n/a
48	chr7:100544220-100544270	T-47D	breast:	n/a
49	chr7:100544220-100544270	BJ	skin:	n/a
50	chr7:100541893-100541943	NHBE	bronchial:	n/a

(count:20 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:100494043..100496246-chr7:100550371..100552219,2	K562	blood:
2	chr7:100532273..100534632-chr7:100540353..100542746,2	K562	blood:
3	chr7:100532273..100534632-chr7:100540353..100542746,2	K562	blood:
4	chr10:7973739..7975897-chr7:100544491..100546980,2	MCF-7	breast:
5	chr7:100486624..100489424-chr7:100545614..100548228,2	MCF-7	breast:
6	chr7:100547706..100549637-chr7:100613917..100615692,2	MCF-7	breast:
7	chr7:100540893..100542602-chr7:100549623..100552320,2	K562	blood:
8	chr7:100490569..100492448-chr7:100550621..100553306,2	MCF-7	breast:
9	chr7:100493649..100495175-chr7:100549463..100550982,2	MCF-7	breast:
10	chr7:100527181..100530465-chr7:100537880..100541406,4	MCF-7	breast:
11	chr7:100549832..100555944-chr7:100607722..100611748,10	K562	blood:
12	chr7:100541427..100545433-chr7:100545850..100548662,4	MCF-7	breast:
13	chr7:100472631..100474215-chr7:100540513..100542514,2	K562	blood:
14	chr7:100527296..100529594-chr7:100538655..100542451,3	MCF-7	breast:
15	chr7:100485287..100488020-chr7:100526128..100528908,2	MCF-7	breast:
16	chr7:100551774..100553775-chr7:100606595..100608318,2	MCF-7	breast:
17	chr7:100549275..100549788-chr7:100702024..100702894,2	MCF-7	breast:
18	chr7:100527181..100530465-chr7:100537880..100541406,4	MCF-7	breast:
19	chr7:100527296..100529594-chr7:100538655..100542451,3	MCF-7	breast:
20	chr7:100549832..100554872-chr7:100605467..100612701,10	K562	blood:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ACHE-5	chr7:100551165-100551637	NONHSAT122427
2	lnc-ACHE-5	chr7:100550661-100550705	NONHSAT122427
3	lnc-ACHE-4	chr7:100549481-100550424	NONHSAT122426
4	lnc-ACHE-5	chr7:100550808-100550858	NONHSAT122427
5	lnc-ACHE-4	chr7:100547228-100547317	NONHSAT122426

No data

Variant related genes	Relation type
ENSG00000228273	TF binding region
MUC3A	TF binding region
ENSG00000235926	TF binding region
ENSG00000228273	CpG island
MUC3A	CpG island
ENSG00000235926	CpG island
ENSG00000087087	chromatin interactions
ENSG00000176125	chromatin interactions
ENSG00000228273	chromatin interactions
ENSG00000169894	chromatin interactions
ENSG00000087085	chromatin interactions
ENSG00000225946	chromatin interactions

Extended variants
information (count: 1872 )
Associated
traits (count: 91 )

Variant overlapped rSNPs/rCNVs (count:1872 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564952687	chr7:100525849-100525850	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs151180072	chr7:100525871-100525872	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs181957321	chr7:100525883-100525884	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs560148810	chr7:100525899-100525900	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs527576645	chr7:100525929-100525930	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs7455552	chr7:100526005-100526006	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs117659527	chr7:100526013-100526014	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs140090059	chr7:100526023-100526024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs187365537	chr7:100526032-100526033	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs566224967	chr7:100526039-100526040	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs150304308	chr7:100526040-100526041	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs534033291	chr7:100526056-100526057	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs538213439	chr7:100526058-100526059	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs147632629	chr7:100526068-100526069	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs566290203	chr7:100526074-100526075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs570746067	chr7:100526093-100526094	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs558203533	chr7:100526119-100526120	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs75465621	chr7:100526120-100526121	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs576195327	chr7:100526122-100526123	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs113695653	chr7:100526130-100526131	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs142298689	chr7:100526164-100526165	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs558735489	chr7:100526193-100526194	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs577178755	chr7:100526225-100526226	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs111633215	chr7:100526226-100526227	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs112735656	chr7:100526227-100526228	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs572280988	chr7:100526232-100526233	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs372942771	chr7:100526237-100526238	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs375804055	chr7:100526238-100526239	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs189324782	chr7:100526243-100526244	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs531483845	chr7:100526247-100526248	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs374442860	chr7:100526266-100526267	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs564869393	chr7:100526270-100526271	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs532229393	chr7:100526277-100526278	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs547104529	chr7:100526282-100526283	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs565654306	chr7:100526289-100526290	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs62482554	chr7:100526290-100526291	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	mRNA abundance
37	rs548445393	chr7:100526293-100526294	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs201223002	chr7:100526296-100526297	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs569918425	chr7:100526300-100526301	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs111728617	chr7:100526303-100526304	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs559098383	chr7:100526305-100526306	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs570905119	chr7:100526306-100526307	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs535098243	chr7:100526307-100526308	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs112553886	chr7:100526309-100526310	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs202059888	chr7:100526310-100526311	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs542943608	chr7:100526325-100526326	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs554861978	chr7:100526326-100526327	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs576393153	chr7:100526328-100526329	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs368372249	chr7:100526343-100526344	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs180823916	chr7:100526353-100526354	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:91)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Breast cancer	21509527	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:444 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:100517200-100527200	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr7:100521400-100527000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr7:100523200-100527400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr7:100524400-100526200	Enhancers	HUES6 Cell Line	embryonic stem cell
5	chr7:100524600-100526200	Enhancers	H1 Cell Line	embryonic stem cell
6	chr7:100524600-100526200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
7	chr7:100524600-100526200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr7:100525000-100526400	Enhancers	HUES64 Cell Line	embryonic stem cell
9	chr7:100525200-100526400	Enhancers	iPS-20b Cell Line	embryonic stem cell
10	chr7:100525600-100526200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr7:100525600-100526400	Enhancers	HUES48 Cell Line	embryonic stem cell
12	chr7:100525800-100526400	Enhancers	iPS-15b Cell Line	embryonic stem cell
13	chr7:100525800-100527000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
14	chr7:100525800-100527400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr7:100526000-100530800	Enhancers	Placenta	Placenta
16	chr7:100526200-100527000	Weak transcription	HUES6 Cell Line	embryonic stem cell
17	chr7:100526200-100527200	Weak transcription	H1 Cell Line	embryonic stem cell
18	chr7:100526200-100527200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
19	chr7:100526200-100527200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr7:100526200-100527400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
21	chr7:100526400-100526600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
22	chr7:100526400-100526800	Weak transcription	HUES48 Cell Line	embryonic stem cell
23	chr7:100526400-100526800	Weak transcription	HUES64 Cell Line	embryonic stem cell
24	chr7:100526400-100526800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
25	chr7:100526600-100526800	Enhancers	iPS-20b Cell Line	embryonic stem cell
26	chr7:100526600-100528400	Enhancers	Placenta Amnion	Placenta Amnion
27	chr7:100526800-100527000	Enhancers	HUES48 Cell Line	embryonic stem cell
28	chr7:100526800-100527000	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr7:100526800-100527000	Active TSS	iPS-20b Cell Line	embryonic stem cell
30	chr7:100526800-100527200	Enhancers	iPS-15b Cell Line	embryonic stem cell
31	chr7:100526800-100527800	Enhancers	Breast Myoepithelial Primary Cells	Breast
32	chr7:100526800-100527800	Enhancers	Aorta	Aorta
33	chr7:100526800-100528200	Enhancers	HMEC	breast
34	chr7:100526800-100528400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr7:100527000-100527200	Active TSS	ES-I3 Cell Line	embryonic stem cell
36	chr7:100527000-100527200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
37	chr7:100527000-100527200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
38	chr7:100527000-100527600	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
39	chr7:100527000-100527600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
40	chr7:100527000-100528000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
41	chr7:100527200-100527400	Enhancers	HUES48 Cell Line	embryonic stem cell
42	chr7:100527200-100527400	Bivalent Enhancer	NH-A	brain
43	chr7:100527200-100527600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
44	chr7:100527200-100527800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
45	chr7:100527200-100527800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
46	chr7:100527200-100527800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr7:100527200-100527800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr7:100527200-100528000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
49	chr7:100527200-100528000	Enhancers	H9 Cell Line	embryonic stem cell
50	chr7:100527200-100528000	Genic enhancers	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links